Sol-Gel Q2 FY26 net loss widens to $3.7 million; revenue drops 96.58% to $591,000

PUBT · 1d ago
Sol-Gel Q2 FY26 net loss widens to $3.7 million; revenue drops 96.58% to $591,000
  • Sol-Gel reported Q2 2026 revenue of $0.6 million, down from $17.3 million a year earlier.
  • Net loss widened to $3.7 million, swinging from net income of $11.6 million; diluted loss per share was $1.13.
  • R&D expense fell to $3.7 million from $4.6 million; G&A declined to $1.0 million from $1.4 million.
  • Cash, cash equivalents, deposits, and marketable securities totaled $49.3 million as of June 30, 2026; runway seen into Q1 2028.
  • Phase 3 SGT-610 Gorlin trial: 9% dropout rate; last patient last visit expected September 2026, top-line results due late November 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sol Gel Technologies Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608200830PRIMZONEFULLFEED9813403) on August 20, 2026, and is solely responsible for the information contained therein.